Analysis of anal sphincter preservation rate according to tumor level and neoadjuvant chemoradiotherapy in rectal cancer patients

Seung Hyuk Baik, Nam Kyu Kim, Kang Young Lee, Seung Kook Sohn, Chang Hwan Cho

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The anal sphincter preservation rate (ASPR) according to tumor level and neoadjuvant chemoradiotherpy (CRT) has not been fully evaluated. Therefore, the aim of this study was to evaluate the correlation between the tumor level, neoadjuvant CRT, and the ASPR in rectal cancer patients. We studied 544 patients (tumor level, 0-6 cm) who underwent curative resection for rectal cancer between 1991 and 2005. Patients were divided six into groups according to tumor level over 1-cm intervals, and the ASPR was evaluated in patients with and without neoadjuvant CRT according to tumor level. Sphincter preservation surgery was performed in 191 patients, and 86 patents underwent neoadjuvant CRT. The overall ASPR was 43.0% (37/86) in patients with neoadjuvant CRT and 33.6% (154/458) in patients without neoadjuvant CRT (P∈=∈0.094). In an analysis according to tumor level, the ASPR was 0.0 vs 0.0% in ≫1 cm, 0.0 vs 2.1% in 1∈≫∈2 cm (P∈=∈0.589), 11.8 vs 16.8% in 2∈≫∈3 cm (P∈=∈0.599), 55.6 vs 20.2% in 3∈≫∈4 cm (P∈=∈0.001), 57.7 vs 45.9% in 4∈≫∈5 cm (P∈=∈0.227), and 66.7 vs 69.5% in 5∈≫∈6 cm (P∈=∈0.827). Neoadjuvant CRT did not increase the ASPR in tumor level within ≫6 cm. However, for the tumor level (3∈≫∈4 cm), neoadjuvant CRT significantly increased the ASPR.

Original languageEnglish
Pages (from-to)176-182
Number of pages7
JournalJournal of Gastrointestinal Surgery
Volume12
Issue number1
DOIs
Publication statusPublished - 2008 Jan 1

Fingerprint

Anal Canal
Chemoradiotherapy
Rectal Neoplasms
Neoplasms
Patents

All Science Journal Classification (ASJC) codes

  • Surgery
  • Gastroenterology

Cite this

@article{cb8cedefff4d4d479796c6c122308a22,
title = "Analysis of anal sphincter preservation rate according to tumor level and neoadjuvant chemoradiotherapy in rectal cancer patients",
abstract = "The anal sphincter preservation rate (ASPR) according to tumor level and neoadjuvant chemoradiotherpy (CRT) has not been fully evaluated. Therefore, the aim of this study was to evaluate the correlation between the tumor level, neoadjuvant CRT, and the ASPR in rectal cancer patients. We studied 544 patients (tumor level, 0-6 cm) who underwent curative resection for rectal cancer between 1991 and 2005. Patients were divided six into groups according to tumor level over 1-cm intervals, and the ASPR was evaluated in patients with and without neoadjuvant CRT according to tumor level. Sphincter preservation surgery was performed in 191 patients, and 86 patents underwent neoadjuvant CRT. The overall ASPR was 43.0{\%} (37/86) in patients with neoadjuvant CRT and 33.6{\%} (154/458) in patients without neoadjuvant CRT (P∈=∈0.094). In an analysis according to tumor level, the ASPR was 0.0 vs 0.0{\%} in ≫1 cm, 0.0 vs 2.1{\%} in 1∈≫∈2 cm (P∈=∈0.589), 11.8 vs 16.8{\%} in 2∈≫∈3 cm (P∈=∈0.599), 55.6 vs 20.2{\%} in 3∈≫∈4 cm (P∈=∈0.001), 57.7 vs 45.9{\%} in 4∈≫∈5 cm (P∈=∈0.227), and 66.7 vs 69.5{\%} in 5∈≫∈6 cm (P∈=∈0.827). Neoadjuvant CRT did not increase the ASPR in tumor level within ≫6 cm. However, for the tumor level (3∈≫∈4 cm), neoadjuvant CRT significantly increased the ASPR.",
author = "Baik, {Seung Hyuk} and Kim, {Nam Kyu} and Lee, {Kang Young} and Sohn, {Seung Kook} and Cho, {Chang Hwan}",
year = "2008",
month = "1",
day = "1",
doi = "10.1007/s11605-007-0254-4",
language = "English",
volume = "12",
pages = "176--182",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "1",

}

Analysis of anal sphincter preservation rate according to tumor level and neoadjuvant chemoradiotherapy in rectal cancer patients. / Baik, Seung Hyuk; Kim, Nam Kyu; Lee, Kang Young; Sohn, Seung Kook; Cho, Chang Hwan.

In: Journal of Gastrointestinal Surgery, Vol. 12, No. 1, 01.01.2008, p. 176-182.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Analysis of anal sphincter preservation rate according to tumor level and neoadjuvant chemoradiotherapy in rectal cancer patients

AU - Baik, Seung Hyuk

AU - Kim, Nam Kyu

AU - Lee, Kang Young

AU - Sohn, Seung Kook

AU - Cho, Chang Hwan

PY - 2008/1/1

Y1 - 2008/1/1

N2 - The anal sphincter preservation rate (ASPR) according to tumor level and neoadjuvant chemoradiotherpy (CRT) has not been fully evaluated. Therefore, the aim of this study was to evaluate the correlation between the tumor level, neoadjuvant CRT, and the ASPR in rectal cancer patients. We studied 544 patients (tumor level, 0-6 cm) who underwent curative resection for rectal cancer between 1991 and 2005. Patients were divided six into groups according to tumor level over 1-cm intervals, and the ASPR was evaluated in patients with and without neoadjuvant CRT according to tumor level. Sphincter preservation surgery was performed in 191 patients, and 86 patents underwent neoadjuvant CRT. The overall ASPR was 43.0% (37/86) in patients with neoadjuvant CRT and 33.6% (154/458) in patients without neoadjuvant CRT (P∈=∈0.094). In an analysis according to tumor level, the ASPR was 0.0 vs 0.0% in ≫1 cm, 0.0 vs 2.1% in 1∈≫∈2 cm (P∈=∈0.589), 11.8 vs 16.8% in 2∈≫∈3 cm (P∈=∈0.599), 55.6 vs 20.2% in 3∈≫∈4 cm (P∈=∈0.001), 57.7 vs 45.9% in 4∈≫∈5 cm (P∈=∈0.227), and 66.7 vs 69.5% in 5∈≫∈6 cm (P∈=∈0.827). Neoadjuvant CRT did not increase the ASPR in tumor level within ≫6 cm. However, for the tumor level (3∈≫∈4 cm), neoadjuvant CRT significantly increased the ASPR.

AB - The anal sphincter preservation rate (ASPR) according to tumor level and neoadjuvant chemoradiotherpy (CRT) has not been fully evaluated. Therefore, the aim of this study was to evaluate the correlation between the tumor level, neoadjuvant CRT, and the ASPR in rectal cancer patients. We studied 544 patients (tumor level, 0-6 cm) who underwent curative resection for rectal cancer between 1991 and 2005. Patients were divided six into groups according to tumor level over 1-cm intervals, and the ASPR was evaluated in patients with and without neoadjuvant CRT according to tumor level. Sphincter preservation surgery was performed in 191 patients, and 86 patents underwent neoadjuvant CRT. The overall ASPR was 43.0% (37/86) in patients with neoadjuvant CRT and 33.6% (154/458) in patients without neoadjuvant CRT (P∈=∈0.094). In an analysis according to tumor level, the ASPR was 0.0 vs 0.0% in ≫1 cm, 0.0 vs 2.1% in 1∈≫∈2 cm (P∈=∈0.589), 11.8 vs 16.8% in 2∈≫∈3 cm (P∈=∈0.599), 55.6 vs 20.2% in 3∈≫∈4 cm (P∈=∈0.001), 57.7 vs 45.9% in 4∈≫∈5 cm (P∈=∈0.227), and 66.7 vs 69.5% in 5∈≫∈6 cm (P∈=∈0.827). Neoadjuvant CRT did not increase the ASPR in tumor level within ≫6 cm. However, for the tumor level (3∈≫∈4 cm), neoadjuvant CRT significantly increased the ASPR.

UR - http://www.scopus.com/inward/record.url?scp=38149024830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149024830&partnerID=8YFLogxK

U2 - 10.1007/s11605-007-0254-4

DO - 10.1007/s11605-007-0254-4

M3 - Article

C2 - 17694418

AN - SCOPUS:38149024830

VL - 12

SP - 176

EP - 182

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 1

ER -